BMI View: High per capita spending on pharmaceuticals and a rising burden of chronic diseases will
support long-term pharmaceutical growth in Saudi Arabia. However, a prolonged period of subdued oil
prices may see Saudi Arabia cut back on high value drug spending – posing a risk to innovative
drugmakers. Our outlook for the country’s healthcare sector is a positive one. As such, the government’s
focus on healthcare will remain a priority, owing to the sensitive nature of the sector and its political
importance. However, cost-containment measures will be encouraged, and over the long-term, the private
sector will play an increasingly important role in the provision of healthcare in Saudi Arabia.
Headline Expenditure Projections
? Pharmaceuticals: SAR31.75bn (USD8.46bn) in 2015 to SAR35.32bn (USD9.42bn) in 2016; +11.3% in
both local currency and US dollar terms. Forecast unchanged from Q116.
? Healthcare: SAR113.11bn (USD30.16bn) in 2015 to SAR123.31bn (USD32.88bn) in 2016; +9.0% in
both local currency and US dollar terms. Forecast in line with Q116.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Saudi Arabia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Saudi Arabia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020) 23
OTC Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Saudi Arabia 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Saudi Arabia 2014-2020) 29
Industry Risk Reward Index 30
Middle East and Africa Risk/Reward Index - Q2 2016 30
Saudi Arabia Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 41
Pricing Regime 43
Reimbursement Regime 46
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Saudi Arabia 2010-2015) 53
Table: Healthcare Personnel (Saudi Arabia 2010-2015) 53
Table: Healthcare Activity (Saudi Arabia 2010-2015) 54
Research & Development 54
Clinical Trials 56
Epidemiology 57
Competitive Landscape 60
Research-Based Industry 60
Table: Multinational Market Activity 63
Generic Drugmakers 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 66
Company Profile 68
GlaxoSmithKline 68
Sanofi 71
SPIMACO 74
TABUK Pharmaceutical Manufacturing 78
Novartis 81
Demographic Forecast 83
Demographic Outlook 83
Table: Population Headline Indicators (Saudi Arabia 1990-2025) 84
Table: Key Population Ratios (Saudi Arabia 1990-2025) 84
Table: Urban/Rural Population & Life Expectancy (Saudi Arabia 1990-2025) 85
Table: Population By Age Group (Saudi Arabia 1990-2025) 85
Table: Population By Age Group % (Saudi Arabia 1990-2025) 86
Glossary 88
Methodology 90
Pharmaceutical Expenditure Forecast Model 90
Healthcare Expenditure Forecast Model 90
Notes On Methodology 91
Risk/Reward Index Methodology 92
Index Overview 93
Table: Pharmaceutical Risk/Reward Index Indicators 93
Indicator Weightings 94

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Saudi Arabia 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Saudi Arabia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Saudi Arabia 2014-2020)
Table: Healthcare Resources (Saudi Arabia 2010-2015)
Table: Healthcare Personnel (Saudi Arabia 2010-2015)
Table: Healthcare Activity (Saudi Arabia 2010-2015)
Table: Multinational Market Activity
Table: Population Headline Indicators (Saudi Arabia 1990-2025)
Table: Key Population Ratios (Saudi Arabia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Saudi Arabia 1990-2025)
Table: Population By Age Group (Saudi Arabia 1990-2025)
Table: Population By Age Group % (Saudi Arabia 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators